Potent, nutrient-rich skin serums are often on the costlier side for most consumers, but the Maelove brand, headed by CEO Jackie Kim, is a highly effective mid-priced product.
Its new serum, Glow Maker, contains star skincare ingredients like skin-brightening vitamin C, moisturizing aloe and glycerin, and water-retaining hyaluronic acid – along with grapeseed extract and ferulic acid. The brand's products are based in research from AI that scanned publicly available product reviews and consolidated them so the researchers could better understand people's skincare needs, and product preferences.
The Maelove brand's products are based in work done by everyone from cancer and brain researchers, to chemical engineers, lawyers, and medical doctors – creating a collection that is both highly efficient and relatively affordable.
Doctor-Produced Serums
The Maelove Glow Maker Serum is Rich with Antioxidants
Trend Themes
1. Mid-priced Skin Serums - Disruptive innovation opportunity: Develop affordable yet highly effective skin serums using potent, nutrient-rich ingredients.
2. AI-driven Skincare Research - Disruptive innovation opportunity: Utilize AI to analyze product reviews and consolidate data for better understanding of consumer skincare needs and preferences.
3. Multidisciplinary Skincare Collaboration - Disruptive innovation opportunity: Foster collaboration between researchers, engineers, and doctors to create highly efficient and affordable skincare products based on various expertise.
Industry Implications
1. Cosmetics - Disruptive innovation opportunity: Introduce mid-priced skincare products with high effectiveness, targeting cost-conscious consumers.
2. Artificial Intelligence - Disruptive innovation opportunity: Develop AI-driven tools to analyze product reviews and extract valuable insights for the skincare industry.
3. Healthcare - Disruptive innovation opportunity: Promote collaboration between healthcare professionals, researchers, and product developers to create affordable and effective skincare solutions.